Beam Therapeutics Inc. (BEAM) shares ended the last trading session 12.6% higher at $16.37. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

There's a bit of excitement added to every Sacramento Kings home win thanks to "The Beam," a purple light that shoots into the sky above the Golden 1 Center in celebration of the victory.

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Working Capital: Approximately $14 million, providing about 35 months of run rate. Beam Global (NASDAQ:BEEM) achieved a 124% increase in revenue over 2022, reaching $49.3 million in 2024.

BEAM Insurance Solutions has acquired KDH Insurance Brokers, further strengthening its presence in the Midlands as it targets £22 million in gross written premiums (GWP) by the end of the year ...

Once submitted, we will try and place you in contact with a suitable Double-Beam Spectrophotometers supplier within 48 hours.

As the final beam of ConnCAT’s future health-job-childcare hub rose on Dixwell Avenue, Kim Harris and Julia Ficklin each thought of generations past and generations to come. For Ficklin, that beam ...

Jim Beam is one of the biggest names in bourbon. Its flagship bottle was the top-selling American whiskey brand from 2019 to 2023, according to a report from The Spirits Business. But the brand ...

BEAM-302 showed 91% corrected M-AAT and 79% drop in mutant Z-AAT at Day 28 in the 60 mg dose cohort. Beam to enroll 75 mg dose cohort and dose first liver disease patient in 2H 2025. China’s new ...